Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC

被引:15
|
作者
Roncari, B.
Pedroni, M.
Maffei, S.
Di Gregorio, C.
Ponti, G.
Scarselli, A.
Losi, L.
Benatti, P.
Roncucci, L.
De Gaetani, C.
Camellini, L.
Lucci-Cordisco, E.
Tricarico, R.
Genuardi, M.
de Leon, M. Ponz
机构
[1] Univ Modena & Reggio Emilia, Dept Med & Med Specialities, I-41100 Modena, Italy
[2] Civil Hosp Carpi, Pathol Unit, Modena, Italy
[3] Univ Modena & Reggio Emilia, Dept Pathol, Modena, Italy
[4] Santa Maria Nuova Hosp, Gastrointestinal Endoscopy Unit, Reggio Emilia, Italy
[5] Catholic Univ A Germelli Sch Med, Inst Med Genet, Rome, Italy
[6] Univ Florence, Sch Med, Dept Clin Pathophysiol, Med Genet Sect, Florence, Italy
关键词
colorectal cancer; HNPCC; immunohistochemistry; MSH6; MSI;
D O I
10.1111/j.1399-0004.2007.00856.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A large majority of constitutional mutations in hereditary non-polyposis colorectal cancer (HNPCC) are because of the MHL1 or MSH2 genes. In a lower fraction of cases, another gene of the mismatch repair (MMR) machinery, MSH6, may be responsible. Families with MSH6 mutations are difficult to recognize, as microsatellite instability (MSI) may not be detectable and immunohistochemistry (IHC) may give ambiguous results. In the present study, we proposed (i) to determine the frequency of MSH6 mutations in a selected population of colorectal cancer patients obtained from a tumor registry, (ii) to assess whether IHC is a suitable tool for selecting and identifying MSH6 mutation carriers. One hundred neoplasms of the large bowel from suspected HNPCC families were analyzed for MSI (BAT25 and BAT26 markers) and immunohistochemical expression of the MSH6 protein. We found on 12 tumors (from different families) showing instability or lack of MSH6 expression. Among these, four potentially pathogenic MSH6 mutations were detected (del A at 2984; del TT at 3119; del AGG cod 385; and del CGT cod 1242) by direct gene sequencing. These represented 12.9% of all families with constitutional mutations of the DNA MMR genes. Thus, some 5% of all HNPCC families are featured by constitutional mutation of the MSH6 gene. This appears, however, as a minimum estimate; routine use of IHC and the study of large numbers of individuals and families with little or no evidence of Lynch syndrome might reveal that mutation of this gene account for a large fraction of HNPCC.
引用
收藏
页码:230 / 237
页数:8
相关论文
共 50 条
  • [41] MSH6 Somatic Mutations in Mediating Temozolomide Resistance in Recurrent Glioblastomas
    Yip, Stephen
    Miao, Jiangyong
    Cahill, Daniel
    Iafrate, A.
    Aldape, Kenneth
    Nutt, Catherine
    Louis, David
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 562 - 562
  • [42] Biochemical basis for dominant mutations in the Saccharomyces cerevisiae MSH6 gene
    Hess, MT
    Mendillo, ML
    Mazur, DJ
    Kolodner, RD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (03) : 558 - 563
  • [43] Recently identified colon cancer predispositions:: MYH and MSH6 mutations
    Kastrinos, Fay
    Syngal, Sapna
    SEMINARS IN ONCOLOGY, 2007, 34 (05) : 418 - 424
  • [44] Familial endometrial cancer in female carriers of MSH6 germline mutations
    Wijnen, J
    de Leeuw, W
    Vasen, H
    van der Klift, H
    Moller, P
    Stormorken, A
    Meijers-Heijboer, H
    Lindhout, D
    Menko, F
    Vossen, S
    Möslein, G
    Tops, C
    Bröcker-Vriends, A
    Wu, Y
    Hofstra, R
    Sijmons, R
    Cornelisse, C
    Morreau, H
    Fodde, R
    NATURE GENETICS, 1999, 23 (02) : 142 - 144
  • [45] Familial endometrial cancer in female carriers of MSH6 germline mutations
    Juul Wijnen
    Wiljo de Leeuw
    Hans Vasen
    Heleen van der Klift
    Pål Møller
    Astrid Stormorken
    Hanne Meijers-Heijboer
    Dick Lindhout
    Fred Menko
    Sandra Vossen
    Gabriela Möslein
    Carli Tops
    Annette Bröcker-Vriends
    Ying Wu
    Robert Hofstra
    Rolf Sijmons
    Cees Cornelisse
    Hans Morreau
    Riccardo Fodde
    Nature Genetics, 1999, 23 : 142 - 144
  • [46] Association of MUTYH and MSH6 germline mutations in colorectal cancer patients
    Dolores Giraldez, Maria
    Balaguer, Francesc
    Caldes, Trinidad
    Sanchez-de-Abajo, Ana
    Gomez-Fernandez, Nuria
    Ruiz-Ponte, Clara
    Munoz, Jenifer
    Garre, Pilar
    Gonzalo, Victoria
    Moreira, Leticia
    Ocana, Teresa
    Clofent, Joan
    Carracedo, Angel
    Andreu, Montserrat
    Jover, Rodrigo
    Llor, Xavier
    Castells, Antoni
    Castellvi-Bel, Sergi
    FAMILIAL CANCER, 2009, 8 (04) : 525 - 531
  • [47] Bias in detection of instability of the (C)8 mononucleotide repeat of MSH6 in tumours from HNPCC patients
    de Leeuw, WJF
    van Puijenbroek, M
    Merx, R
    Wijnen, JT
    Bröcker-Vriends, AHJT
    Tops, C
    Vasen, H
    Cornelisse, CJ
    Morreau, H
    ONCOGENE, 2001, 20 (43) : 6241 - 6244
  • [48] Prevalence of mutations in MSH6, PMS1 and PMS2 gene in Brazilian families with Lynch syndrome
    Silva, Felipe C.
    Torrezan, Giovana T.
    Lisboa, Bianca G.
    Santos, Erika M.
    Gomy, Israel
    Rossi, Benedito M.
    Ferreira, Fabio O.
    Carraro, Dirce M.
    CANCER RESEARCH, 2012, 72
  • [49] Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
    Colin C. Pritchard
    Colm Morrissey
    Akash Kumar
    Xiaotun Zhang
    Christina Smith
    Ilsa Coleman
    Stephen J. Salipante
    Jennifer Milbank
    Ming Yu
    William M. Grady
    Jonathan F. Tait
    Eva Corey
    Robert L. Vessella
    Tom Walsh
    Jay Shendure
    Peter S. Nelson
    Nature Communications, 5
  • [50] Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome
    Rahner, Nils
    Friedrichs, Nicolaus
    Wehner, Maria
    Steinke, Verena
    Aretz, Stefan
    Friedl, Waltraut
    Buettner, Reinhard
    Mangold, Elisabeth
    Propping, Peter
    Walldorf, Constanze
    ACTA ONCOLOGICA, 2007, 46 (06) : 763 - 769